Clinuvel Pharmaceuticals Ltd.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLVLY and other ETFs, options, and stocks.About CLVLY
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug.
CEOPhilippe Jacques Wolgen
CEOPhilippe Jacques Wolgen
Employees—
Employees—
HeadquartersMelbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded1999
Founded1999
Employees—
Employees—
CLVLY Key Statistics
Market cap412.01M
Market cap412.01M
Price-Earnings ratio17.46
Price-Earnings ratio17.46
Dividend yield0.32%
Dividend yield0.32%
Average volume1.28K
Average volume1.28K
High today$8.21
High today$8.21
Low today$8.00
Low today$8.00
Open price$8.00
Open price$8.00
Volume600.00
Volume600.00
52 Week high$9.00
52 Week high$9.00
52 Week low$6.00
52 Week low$6.00
Stock Snapshot
Clinuvel Pharmaceuticals Ltd.(CLVLY) stock is priced at $8.21, giving the company a market capitalization of 412.01M. It carries a P/E multiple of 17.46 and pays a dividend yield of 32.0%.
On 2025-12-14, Clinuvel Pharmaceuticals Ltd.(CLVLY) stock moved within a range of $8.00 to $8.21. With shares now at $8.21, the stock is trading +2.6% above its intraday low and 0.0% below the session's peak.
Trading volume for Clinuvel Pharmaceuticals Ltd.(CLVLY) stock has reached 600, versus its average volume of 1.28K.
The stock's 52-week range extends from a low of $6.00 to a high of $9.00.
The stock's 52-week range extends from a low of $6.00 to a high of $9.00.